Molecular Diagnostics
Urine-Based, Non-Invasive Molecular Test Accurately Detects Bladder Cancer
A new study aims to evaluate the performance of a non-invasive, quantitative real-time PCR (qPCR) assay designed to detect two DNA methylation biomarkers in urine specimens from patients suspected of having bladder cancer. More...25 Nov 2022
Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC
A compact immunoanalyzer with superior assay performance combines the accuracy of a full-scale lab analyzer with the flexibility of a mobile solution, making it an ideal analysis system for laboratories, hospitals and medical offices where fast quantitative results (with full-scale lab quality) are required at the point of care. More...24 Nov 2022
Blood Test Could Screen for Changes in Proteins Prior to Breast Cancer Diagnosis
Researchers have found changes in the levels of particular proteins in people’s blood up to two years before they were diagnosed with breast cancer. The study could form the basis of blood testing for people with a genetic predisposition or a family history of breast cancer to ensure the disease is diagnosed early when the chances of survival are greatest. More...23 Nov 2022
Tumor Biopsies Analysis Performed on Newly-diagnosed B-cell Neoplasms
Comprehensive genomic analyses of tumor biopsies from patients with newly-diagnosed germinal center B cell (GCB) diffuse large B cell/high grade B cell lymphoma (DLBCL/HGBL) have identified molecular subtypes predictive of inferior survival, which are characterized by somatic mutations that can be detected through clinical laboratory mutation analysis (CLMA). More...22 Nov 2022
Acute COVID-19 Infections Are Characterized by Elevated Blood Levels of IL-26
Increased systemic IL-26 was found to be associated with markers of hyperinflammation and tissue damage in patients with acute COVID-19, suggesting that it may be a potential target for diagnosis, monitoring, and therapy in this disease. More...22 Nov 2022
New Tool Assesses Cost of ctDNA Testing
Circulating tumor DNA (ctDNA) is a promising new biomarker with multiple potential applications in cancer care. Estimating total cost of ctDNA testing is necessary for reimbursement and implementation, but challenging because of variations in workflow. More...22 Nov 2022
Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
In Other News
Multiplex Vaginal Panel Identifies Three Distinct Conditions in One Hour
Novel Assay Enables Simultaneous Detection of SMA and SCID in Newborns
Simple Blood Test Could More Than Double Liver Cancer Detection Rate in High-Risk Population
First-Ever Saliva-Based Concussion Test to Be Available in 2023
AI Blood Test Detects Liver Cancer
Non-Invasive Saliva Test Predicts Future Risk for Alzheimer's
A Urine Test for Detection and Management of Cystic Fibrosis
Gene Signature Identifies Patients with Long-term Lyme Disease
Direct Real-Time PCR Protocol Detects Monkeypox Virus
Handheld Diagnostic Lab Offers POC Solution for Future Pandemics
Three-Protein Signature Blood Test Can Detect Undiagnosed Prediabetes
Novel Variant of Phosphorylated Tau Helps Fine Tune Early Diagnosis of Alzheimer’s Disease
POC Molecular Diagnostics Analyzer for Infectious Diseases Provides On-The-Spot Results
Rapid Test for G6PD Deficiency Runs on Toaster-Sized Instrument and Delivers Results in 15 Minutes at POC
New Urine Test Could Detect Childhood Kidney Disease Earlier than Current Assays
Breakthrough Diagnostic Technology Enables Quantitative Five-Minute Tests
World’s First Rapid Saliva-Based Pregnancy Test Set for Multi-Country Launch
Ultra-Fast Real-Time PCR Platform Could Revolutionize POC Molecular Diagnostics
Personalizing Whole Genome Sequencing Doubles Diagnosis of Rare Diseases
New Blood Test to Help Physicians Prevent Major Cardiovascular Events in Women with Lupus
Accurate Genetic Assay Identifies Human Neutrophil Antigen 2 Deficiency
Levels of the MicroRNA MiR-145 Predict Likelihood of Breast Cancer Recurrence
Nose Swabs May Distinguish Babies with RSV Needing Longer Intensive Care
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.